Megan O'Meara

Megan O'Meara currently serves as the Interim Oncology Chief Development Officer and Senior Vice President, Head of Early Clinical Development at Pfizer, starting in December 2023. Prior to this role, Megan O'Meara was with Seagen from March 2020 to December 2023, where positions held included Senior Vice President, Head of Clinical Development, Senior Vice President, Head of Early Stage Development, and Vice President, Head of Early Stage Development. Megan O'Meara's educational background includes a fellowship in Hematology-Oncology and a residency in Internal Medicine, both obtained from the University of Washington - School of Medicine.